Clonal Hit-Expansion Case Study
Abterra Bio uses next-generation sequencing to mine the clonal lineage of serum-identified antibodies. This method rescues relatives of hits that are within a clone and increases diversity in your antibody discovery campaign.
Watch the full presentation, “Next-Generation Repertoire Sequencing for Mining Single Domain Antibodies”, that was given by our CSO, Stefano Bonissone, at the PEGS Boston Virtual Summit 2021.
Read more on our major findings from a recent Alicanto’s analysis of the llama immune response to immunization.